Clinical Research
person

Krisztina K.

Country
Hungary
Department
Private praxis

Research Overview

assignment
13
Clinical Trials ·
location_city
2
Research Sites

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
756
Sites with multiple studies

Has run more than one trial at 756 of 1359 partner sites.

Specializations

Cardiovascular risk reduction

Clinical research activity is centered on prevention of major cardiovascular events in people with atherosclerotic cardiovascular disease, high cardiovascular risk, and related metabolic risk profiles. The work includes therapies targeting lipid-driven risk, vascular inflammation, and event prevention in established or primary-prevention settings.

  • Major adverse cardiovascular events (MACE)
  • Lipids and lipoprotein(a)
  • Hypertension and obesity
  • Type 2 diabetes with cardiovascular disease

This area reflects involvement in therapies aimed at reducing myocardial infarction, stroke, and coronary revascularization risk.

Heart failure and post-infarction care

Another major focus is heart failure, including heart failure with preserved ejection fraction, heart failure with reduced ejection fraction, and broader left ventricular dysfunction after myocardial infarction. The trial portfolio also includes symptomatic and event-based approaches in chronic and acute heart failure populations.

  • HFpEF and HFrEF
  • Post-myocardial infarction ventricular impairment
  • Worsening heart failure
  • Cardiorenal-metabolic overlap

Therapeutic interest extends to strategies that address clinical outcomes, functional status, and biomarker-guided heart failure management.

Pulmonary and airway disease

Clinical involvement also covers chronic respiratory disorders, with emphasis on chronic obstructive pulmonary disease, asthma, and bronchiectasis. Research activity includes treatment options for airflow limitation, exacerbation prevention, and control of persistent respiratory symptoms.

  • COPD
  • Asthma
  • Bronchiectasis
  • Exacerbation prevention

This domain highlights interest in therapies designed to improve lung function and reduce respiratory events across obstructive airway disease.

Metabolic and anti-inflammatory disorders

The investigator’s research landscape includes obesity, overweight, and inflammatory diseases such as ulcerative colitis. Additional activity spans diabetic sensorimotor polyneuropathy, reflecting attention to metabolic complications and symptom burden in chronic disease.

  • Obesity-related cardiovascular risk
  • Ulcerative colitis
  • Diabetic polyneuropathy
  • Metabolic syndrome-related complications

These interests connect metabolic disease management with organ-specific outcomes and symptom control.

Neurological, vascular, and women’s health

Additional clinical interests include acute ischemic stroke, atrial fibrillation, and chronic venous ulcers, along with a women’s health study area involving primary dysmenorrhea and contraception. This broadens the portfolio into cerebrovascular care, thromboembolic prevention, wound healing, and reproductive health.

  • Acute ischemic stroke
  • Atrial fibrillation
  • Chronic venous ulcers
  • Primary dysmenorrhea and contraceptive efficacy

These areas show involvement in both vascular event prevention and targeted care for gynecologic and wound-related conditions.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.